Advancing Cancer Research: Qualification Studies of the nCounter PanCancer IO 360 Gene Expression Panel

Advancing Cancer Research: Qualification Studies of the nCounter PanCancer IO 360 Gene Expression Panel

This white paper explores the qualification studies of the NanoString nCounter PanCancer IO 360 Gene Expression Panel, emphasizing its role in immuno-oncology research. The panel examines 770 genes across 16 pathways, providing insights into tumor-immune interactions and identifying potential biomarkers for immunotherapy.